ETF

Dividend Safety Check: VYMI and International High-Dividend Income

Photo of John Seetoo
By John Seetoo Published

Quick Read

  • Foreign companies paying dividends once or twice yearly create VYMI's quarterly lumpiness, which reflects calendar mechanics rather than evidence of income instability.

  • VYMI distributions grew from $2.85 to $3.32 per share between 2023 and 2025, funded by real multinational dividends rather than return of capital.

  • VYMI's 27% one-year and 80% five-year gains confirm distributions aren't eroding NAV, the failure mode that sinks most high-yield products.

  • Are you ahead, or behind on retirement? SmartAsset's free tool can match you with a financial advisor in minutes to help you answer that today. Each advisor has been carefully vetted, and must act in your best interests. Don't waste another minute; learn more here.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Dividend Safety Check: VYMI and International High-Dividend Income

© RORONOR / Shutterstock.com

The Vanguard International High Dividend Yield ETF (NASDAQ:VYMI) sits in a lot of income portfolios as the foreign-stock complement to a domestic dividend sleeve, and its payouts have grown noticeably over the past three years. VYMI distributed $3.3151 per share across 2025, up from $2.8473 in 2023, and the fund has already paid $1.9649 through the first two 2026 distributions. The question every VYMI holder should be asking: is that income stream durable, or are we looking at a lumpy foreign payout that could shrink in the next currency swing or European bank cycle?

How VYMI Actually Generates Its Yield

VYMI tracks the FTSE All-World ex-US High Dividend Yield Index, which screens international companies expected to pay above-average dividends. The result is a sprawling portfolio of 1,602 positions across developed and emerging markets, run at a rock-bottom expense ratio of 0.07%. That fee matters: on roughly $20 billion in net assets, Vanguard is skimming almost nothing off the dividends flowing back to shareholders.

The income comes directly from underlying company payouts. Foreign firms tend to pay once or twice a year rather than quarterly, which is why VYMI’s distributions swing so much: $1.2569 in June 2026 versus $0.708 in March 2026. That swing is just calendar mechanics.

The Top Holdings Doing the Heavy Lifting

The income backbone is concentrated in mature, cash-generative multinationals. Roche is the largest position at 1.56% of net assets, followed by Shell at 1.41%, UBS at 0.76%, Novo Nordisk at 0.74%, and Unilever at 0.67%. These are exactly the kind of businesses that anchor a durable dividend: pharma with pricing power, an integrated oil major that has held its payout through commodity cycles, a global bank rebuilt post-2008, and two consumer staples with pricing on essentials.

The real risks are Shell’s sensitivity to oil, Novo Nordisk’s dependence on GLP-1 pricing, and UBS’s exposure to European credit conditions. None of those individually threaten the distribution, but they add cyclicality that a US utility ETF would not carry.

Country, Sector, and Currency Exposure

VYMI leans heavily into European financials and consumer names, with meaningful weight in Chinese equities across banking, energy, and utilities, plus positions in Japan, India, Brazil, and the Gulf. That breadth is genuine diversification, but the Chinese sleeve carries dividend-policy risk that US investors do not face at home.

Currency is the wild card. With the dollar buying roughly €0.88 and Morningstar and Franklin Templeton both flagging a weakening dollar backdrop into 2026, translated foreign dividends could actually get a tailwind. When foreign currencies strengthen, the same euro or yen dividend converts into more dollars in your account.

Total Return, Not Just the Check

VYMI is up 27% over the past year and 80% over five years, closing near $98. The distribution is not being funded by NAV erosion, which is the failure mode that sinks many high-yield products.

Competition from the 10-year Treasury near 4.4% and the Fed funds rate at 3.75% is real, but VYMI’s yield plus growth still clears that bar for investors who want equity upside.

Is VYMI’s Payout Actually Durable?

VYMI’s distribution is safe in the sense that matters: it is backed by real dividends from profitable multinationals, not option premium or return of capital. Expect continued lumpiness between quarters and modest year-to-year variability tied to currency and European bank payouts. For investors pairing it with a US high-dividend fund like VYM, VYMI is doing its job. Holders looking for a smooth quarterly check will find the seasonality frustrating and should look elsewhere.

Contact [email protected] for any questions or corrections.

Photo of John Seetoo
About the Author John Seetoo →

After 15 years on Wall Street with 7 of them as Director of Corporate and Municipal Bond Trading for a NYSE member firm, I started my own project and corporate finance consultancy. Much of the work involves writing business plans, presentations, white papers and marketing materials for companies seeking budgetary allocations for spinoffs and new initiatives or for raising capital for expansion or startup companies and entrepreneurs. On financial topics, I have been published under my own byline at The Motley Fool, 247wallst.com, DealFlow Events’ Healthcare Services Investment Newsletter and The Microcap Newsletter, among others.  Additionally, I have done freelance ghostwriting writing and editing for several financial websites, such as Seeking Alpha and Shmoop Financial. I have also written and been published on a variety of other topics from music, audiophile sound and film to musical instrument history, martial arts, and current events.  Publications include Copper Magazine, Fidelity (Germany), Blasting News, Inside Kung-Fu, and other periodicals.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

MRNA Vol: 5,704,316
UHS Vol: 276,889
HCA Vol: 593,969
COIN Vol: 4,323,727
VRTX Vol: 389,819

Top Losing Stocks

CTRA Vol: 73,319,495
TER Vol: 1,057,186
KLA
KLAC Vol: 4,838,411
LRCX Vol: 4,068,179
AMAT Vol: 3,623,859